26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

IV. Disorders <strong>of</strong> Hemostasis<br />

313<br />

<strong>of</strong> gestation; however, values return to normal by 7 to 14<br />

days postpartum ( Moser et al ., 1998 ). This change is more<br />

notable in normal dogs but does also occur in type I vWD<br />

patients ( Moser et al ., 1998 ). It has been suggested that<br />

this may be a result <strong>of</strong> rapidly dividing endothelial cells in<br />

a highly vascular placenta ( Moser et al ., 1998 ). In contrast,<br />

there is no significant change in vWF concentration during<br />

the estrus cycle ( Moser et al ., 1998 ). Age can also have<br />

an effect on the vWF concentration, with younger puppies<br />

generally having lower concentrations that gradually<br />

approach mean adult values by 11 weeks <strong>of</strong> age ( Mansell<br />

and Parry, 1992 ).<br />

In humans, patient response to desmopressin has a positive<br />

correlation with the level <strong>of</strong> platelet vWF ( Ewenstein,<br />

1997 ). Vasopressin stimulates V2 vasopressin receptors,<br />

resulting in the release <strong>of</strong> intracellular stores <strong>of</strong> vWF ( Brooks,<br />

2000 ). A study involving normal dogs and Doberman pinschers<br />

with vWD was conducted in order to assess the effect<br />

<strong>of</strong> exercise, DDAVP, and epinephrine on vWF concentration<br />

and FVIII activity ( Meyers et al ., 1990a ). The vWF-deficient<br />

dogs were unable to sustain intense exercise for longer than<br />

30 min, whereas the normal dogs were able to complete a<br />

10 km run in 40 min. An increase in FVIII activity was noted<br />

in the normal dogs that was related to the intensity <strong>of</strong> exercise<br />

and increased blood lactate concentrations, although the<br />

basis for the increase was not clear. vWF increased in these<br />

dogs to a greater extent than FVIII. There was no significant<br />

change in FVIII or vWF concentration in the vWD-positive<br />

dogs. Although their level <strong>of</strong> exercise was less than that <strong>of</strong> the<br />

normal dogs, the equivalent exercise was sufficient to cause<br />

an increase in vWF:Ag concentration <strong>of</strong> 30% in the normal<br />

dogs. The increase in vWF:Ag and FVIII concentrations after<br />

infusion <strong>of</strong> DDAVP in normal dogs is less than observed in<br />

humans, and some dogs react poorly to this therapy ( Meyers<br />

et al ., 1990a ). In the Meyers et al . study, the vWF:Ag concentration<br />

increased in normal dogs after treatment with DDAVP.<br />

Although the increase noted in the vWF-deficient dogs was<br />

less than 0.1 U/ml, bleeding time decreased in three <strong>of</strong> six <strong>of</strong><br />

these dogs. This finding suggested that DDAVP may induce<br />

the release <strong>of</strong> the high-molecular-weight (and therefore more<br />

active) forms <strong>of</strong> vWF; however, Callan et al . (2005) confirmed<br />

through multimer analysis that DDAVP produces an<br />

increase in all multimer sizes. Finally, whereas the vWF:Ag<br />

concentration increased 30 min after administration <strong>of</strong> epinephrine<br />

in the normal dogs, there was no change in FVIII<br />

activity, nor were there changes in either factor in the vWFdeficient<br />

dogs. Breed variations have also been noted, for<br />

example Airedale terriers tend to have decreased concentrations<br />

<strong>of</strong> vWF compared to control dogs, yet a history <strong>of</strong><br />

bleeding is rare ( Thomas, 1996 ).<br />

2. Platelet Number<br />

Typical clinical signs <strong>of</strong> thrombocytopenia include petechiae<br />

and ecchymoses, bleeding from mucosal surfaces, and<br />

cutaneous bruising. As mentioned (see Section IV.A.1.a),<br />

with the exception <strong>of</strong> petechiae, these signs are similar to<br />

those noted in patients with vWD.<br />

Greyhounds and Cavalier King Charles spaniels<br />

(CKCS) have been shown to have lower platelet numbers<br />

when compared to other breeds, without apparent consequence<br />

( Cowan et al ., 2004 ; Sullivan et al ., 1994 ). In addition<br />

to decreased platelet numbers, in 51% <strong>of</strong> the CKCS<br />

studied, 33% exhibited macrothrombocytes ( Cowan et al .,<br />

2004 ). In fact, the platelet counts in those dogs with macrothrombocytes<br />

were significantly lower than in CKCS<br />

dogs with normal-sized platelets ( Cowan et al ., 2004 ).<br />

The apparent connection between platelet size and number<br />

in these dogs is not surprising based on the association<br />

between platelet mass and TPO concentration (see Section<br />

II.B.1). Although, as mentioned, this platelet anomaly is<br />

benign, there is a decreased platelet aggregation response<br />

to ADP in CKCS ( Cowan et al ., 2004 ).<br />

3. Platelet Function<br />

As noted previously (see Section II.B.2), the GPIIb-IIIa<br />

integrin is essential for platelet aggregation. A deficiency<br />

<strong>of</strong> this integrin results in thrombasthenic thrombopathia,<br />

also known as Glanzmann’s thrombasthenia. This deficiency<br />

has been identified in humans, dogs (otterhounds<br />

and Great Pyrenees), and horses. <strong>Clinical</strong> signs <strong>of</strong> bleeding<br />

in affected canine patients are generally recognized<br />

before 1 year <strong>of</strong> age and include mucosal hemorrhage,<br />

melena, hematuria, cutaneous ecchymoses, and excessive<br />

surgical bleeding ( Boudreaux and Catalfamo, 2001 ). In<br />

platelet aggregation studies, affected platelets will undergo<br />

shape change but fail to aggregate normally. Abnormal in<br />

vitro clot retraction is also typical <strong>of</strong> this disease and has<br />

been used as a screening tool; however, this test is not reliable<br />

for identification <strong>of</strong> carrier animals ( Boudreaux and<br />

Catalfamo, 2001 ). Documentation <strong>of</strong> decreased or absent<br />

membrane GPIIb-IIIa through flow cytometry or electrophoretic<br />

studies provides a definitive diagnosis. Thus far,<br />

two genetic defects have been identified in Great Pyrenees<br />

dogs, and a single defect in otterhounds ( Boudreaux and<br />

Catalfamo, 2001 ; Lipscomb et al ., 2000 ). Similar to the<br />

dog, equine cases also present with mucosal bleeding,<br />

and they have markedly impaired platelet aggregation and<br />

markedly decreased clot retraction ( Livesey et al ., 2005 ).<br />

A single genetic defect has been identified in the horse and<br />

was consistent between two affected horses <strong>of</strong> different<br />

breeds ( Christopherson et al ., 2006 ).<br />

Platelet storage pool defects, specifically a deficiency<br />

<strong>of</strong> dense granules and their contents, result in thrombopathia<br />

in Chediak-Higashi syndrome (CHS). In both cattle<br />

and humans affected with this disease, compared to unaffected<br />

individuals, platelet aggregation was decreased in<br />

response to collagen; concentrations <strong>of</strong> serotonin, ATP,<br />

and ADP were decreased; and the ratio <strong>of</strong> ATP:ADP was<br />

abnormally increased ( Bell et al ., 1976 ). Similarly, in CHS<br />

cats, platelet aggregation required considerably higher

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!